Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

Conditions: Liver Transplantation; Immunosuppression Interventions: Drug: XR-tacrolimus QD + MMF BID; Drug: LCP-tacrolimus QD + MMF BID; Drug: LCP-tacrolimus QD + MMF QD Sponsors: University Hospital, Limoges Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials